Aziyo Biologics Overview
- Founded
-
2015
- Status
-
Public
- Employees
-
157
- Stock Symbol
-
AZYO
- Investments
-
1
- Share Price
-
$5.88
- (As of Thursday Closing)
Aziyo Biologics General Information
Description
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Contact Information
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
- 12510 Prosperity Drive
- Suite 370
- Silver Spring, MD 20904
- United States
+1 (240) 000-0000
Aziyo Biologics Timeline
Aziyo Biologics Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.88 | $6.06 | $4.10 - $12.89 | $80.1M | 13.6M | 10.5K | -$2.46 |
Aziyo Biologics Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 73,512 | 84,937 | 224,388 | |
| Revenue | 46,001 | 47,390 | 42,682 | 42,901 |
| EBITDA | (18,950) | (15,723) | (12,302) | (2,672) |
| Net Income | (27,914) | (24,832) | (21,825) | (11,939) |
| Total Assets | 59,926 | 67,170 | 82,810 | 44,772 |
| Total Debt | 22,977 | 23,232 | 30,635 | 25,531 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Aziyo Biologics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aziyo Biologics Patents
Aziyo Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210269775-A1 | Placental tissue compositions and methods | Pending | 28-Feb-2020 | 0000000000 | |
| US-20190365948-A1 | Lyophilized placental composite sheet and uses thereof | Abandoned | 27-Jan-2017 | 000000000 |
Aziyo Biologics Executive Team (10)
Aziyo Biologics Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000 | Aziyo Biologics | Board Member | 000 0000 |
| 0000000 00000 00.0 | Tissue Banks International | Board Member | 000 0000 |
| 00000 00000 | Self | Chairman & Board Member | 000 0000 |
| 0000000 0000 | HighCape Capital | Board Member | 000 0000 |
| 00000000 000000 | Aziyo Biologics | Board Member | 000 0000 |
Aziyo Biologics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Aziyo Biologics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aziyo Biologics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 31-May-2017 | 0000000000 | Surgical Devices | 0000 0000 |
Aziyo Biologics Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000000 00000000 | Surgical Devices | Roswell, GA | 0000 |